Most cited papers from Theravectys (France)

Theravectys (France)

What are the most cited papers from Theravectys (France)?

The most cited paper from Theravectys (France) is "A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations" (Ludivine Grzelak et al., 2020), with 277 citations. Next come "IgA dominates the early neutralizing antibody response to SARS-CoV-2" (174) and "Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study" (146).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 55 papers. Every paper with more than 5 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations Ludivine Grzelak et al. · Science Translational Medicine Open access	17 Aug 2020	277
2	IgA dominates the early neutralizing antibody response to SARS-CoV-2 Delphine Sterlin et al. · medRxiv PreprintOpen access	11 Jun 2020	174
3	Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study Thomas Roederer, Bastien Mollo, C. C. N. Vincent et al. · The Lancet Public Health Open access	7 Feb 2021	146
4	Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models Min‐Wen Ku et al. · Cell Host & Microbe Open access	17 Dec 2020	145
5	SIRT1 Overexpression in Mouse Hippocampus Induces Cognitive Enhancement Through Proteostatic and Neurotrophic Mechanisms Rubén Corpas, Susana Revilla, Suzanna Ursulet et al. · Molecular Neurobiology Book chapter	10 Sep 2016	131
6	TMPRSS2 is a functional receptor for human coronavirus HKU1 Nell Saunders et al. · Nature Open access	25 Oct 2023	119
7	Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France Samira Fafi‐Kremer et al. · EBioMedicine Open access	31 Jul 2020	114
8	SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020 Arnaud L Fontanet et al. · Eurosurveillance Open access	15 Apr 2021	110
9	SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission Arnaud L Fontanet, Rebecca Grant, Laura Tondeur et al. · medRxiv PreprintOpen access	29 Jun 2020	98
10	Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance Stéphane Le Vu et al. · Nature Communications Open access	21 May 2021	95
11	Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies Jérémy Dufloo, Ludivine Grzelak, Isabelle Staropoli et al. · Cell Reports Medicine Open access	21 Apr 2021	93
12	SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors Ludivine Grzelak et al. · medRxiv PreprintOpen access	24 Apr 2020	90
13	Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α Alexis Mathian et al. · Annals of the Rheumatic Diseases Open access	16 Aug 2022	86
14	BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus Quentin Moyon, Delphine Sterlin, Makoto Miyara et al. · Annals of the Rheumatic Diseases Open access	4 Oct 2021	84
15	A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice Claude Roth, Tineke Cantaert, Chloé Colas et al. · Frontiers in Immunology Open access	21 Jun 2019	83
16	HLA-G Neo-Expression on Tumors Maria Loustau, François Anna, Raphaelle Dréan et al. · Frontiers in Immunology Open access	14 Aug 2020	76
17	Pratiques spatiales transnationales et stratégies de mobilité des commerçantes tunisiennes Camille Schmoll · Revue européenne de migrations internationales Open access	2005	71
18	Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2 Cyril Planchais et al. · The Journal of Experimental Medicine Open access134 authors	21 May 2022	70
19	High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris François Anna et al. · European Journal of Immunology Open access	Dec 2020	67
20	A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection Meetali Singh, Maxime Chazal, Piergiuseppe Quarato et al. · EMBO Reports Open access	16 Dec 2021	62
21	Lentiviral Vector-Based Prime/Boost Vaccination against AIDS: Pilot Study Shows Protection against Simian Immunodeficiency Virus SIVmac251 Challenge in Macaques Anne‐Sophie Beignon, Karine Mollier, Christelle Liard et al. · Journal of Virology Open access	18 Aug 2009	56
22	First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G François Anna, Elodie Bôle‐Richard, Joël LeMaoult et al. · Journal for ImmunoTherapy of Cancer Open access	Mar 2021	50
23	Lentiviral vector induces high-quality memory T cells via dendritic cells transduction Min‐Wen Ku, Pierre Authié, Fabien Névo et al. · Communications Biology Open access	10 Jun 2021	48
24	Habiter, le propre de l’humain : Villes, territoires et philosophie Thierry Paquot, Michel Lussault, Christiane Younès · Philosophie Magazine	Dec 2007	43
25	Le quartier Marie‐Hélène Bacqué, Sylvie Fol · La Découverte eBooks Book chapter	2007	40
26	Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic mice Min‐Wen Ku et al. · EMBO Molecular Medicine Open access	15 Oct 2021	35
27	Use of lentiviral vectors in vaccination Min‐Wen Ku, Pierre Charneau, Laleh Majlessi · Expert Review of Vaccines Open access	10 Oct 2021	35
28	Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus Ignacio García Fernández, Nell Saunders, S. Duquerroy et al. · Cell Open access	3 Jul 2024	32
29	A Single Dose of NILV-Based Vaccine Provides Rapid and Durable Protection against Zika Virus Min‐Wen Ku, François Anna, Philippe Souque et al. · Molecular Therapy Open access	20 May 2020	29
30	New insights into CAR T cell-mediated killing of tumor cells David Espie, Emmanuel Donnadieu · Frontiers in Immunology Open access	15 Sep 2022	28
31	Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation Makoto Miyara et al. · Frontiers in Immunology Open access	11 Feb 2022	21
32	Therapeutic vaccination with lentiviral vector in HBV-persistent mice and two inactive HBsAg carriers Yumeng Zhang, Maryline Bourgine, Yanmin Wan et al. · Journal of Hepatology	11 Oct 2023	20
33	Cosmopolitisme au quotidien et circulations commerciales à Naples Camille Schmoll · Cahiers de la Méditerranée Open access	2003	19
34	Pre-COVID-19 humoral immunity to common coronaviruses does not confer cross-protection against SARS-CoV-2 Makoto Miyara et al. · medRxiv PreprintOpen access	15 Aug 2020	18
35	L'inégalité face à la mobilité : du constat à l'injonction Marie‐Hélène Bacqué, Sylvie Fol · HAL (Le Centre pour la Communication Scientifique Directe) Open access	2007	17
36	High seroprevalence of SARS-CoV-2 antibodies among people living in precarious situations in Ile de France Thomas Roederer et al. · medRxiv PreprintOpen access	9 Oct 2020	16
37	Full eradication of pre‐clinical human papilloma virus‐induced tumors by a lentiviral vaccine Laëtitia Douguet, Ingrid Fert, Jodie Lopez et al. · EMBO Molecular Medicine Open access	7 Sep 2023	15
38	Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC Ching‐Lien Wu, Julien Caumartin, Giada Amodio et al. · Frontiers in Immunology Open access	11 Jan 2021	15
39	Stratégies de positionnement et trajectoires d'architectes Véronique Biau · Sociétés contemporaines Open access	1998	14
40	Autophagy machinery as exploited by viruses Christian Münz et al. · Autophagy Reports Open access	18 Mar 2025	13
41	IRG1 controls host responses to restrict Mycobacterium tuberculosis infection Arnaud Machelart, Imène Belhaouane, Nathalie Deboosère et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	8 Sep 2019	13
42	Keeping space public: Times Square (New York) and the Senegalese peddlers Stéphane Tonnelat · Cybergeo Open access	2011	13
43	CAR T-cell behavior and function revealed by real-time imaging David Espie, Emmanuel Donnadieu · Seminars in Immunopathology	23 Jan 2023	10
44	sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs Andrea Di Gioacchino, Rachel Legendre, Yannis Rahou et al. · RNA Open access	22 Dec 2021	10
45	Aller au cimetière à Salé (Maroc): les nouvelles dimensions spatiales de pratiques sociales en déclin Pascale Philifert · Espaces et sociétés Open access	2002	10
46	Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers Anastasia Demidova, Laëtitia Douguet, Ingrid Fert et al. · Expert Review of Vaccines Open access	8 Jul 2024	9
47	A virus-encoded microRNA contributes to evade innate immune response during SARS-CoV-2 infection Meetali Singh, Maxime Chazal, Piergiuseppe Quarato et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	9 Sep 2021	9
48	Development of an Anti-HTLV-1 Vaccine for the Treatment of Adult T-Cell Leukemia/Lymphoma Déborah Revaud, Ana Bejanariu, Lamya Loussaief et al. · Blood	3 Dec 2015	8
49	Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma Antoine Domenger, Daniela Ricci, Véronique Mayau et al. · Frontiers in Oncology Open access	27 Jan 2023	7
50	The 1900 Paris Health Survey Yankel Fijalkow · Cairn.info	2004	7

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.